https://www.rttnews.com/corpinfo/fdacalendar.aspx
Subcutaneous Efgartigimod (BLA)
06/20/2023
FDA decision on SC efgartigimod for the treatment of generalized myasthenia gravis (gMG) in adults
Approved on June 20
SRP-9001 (BLA)
06/22/2023
FDA decision on SRP-9001 for the Treatment of Ambulant Individuals with Duchenne Muscular Dystrophy
Pending-
Aflibercept 8 mg (BLA)
06/27/2023
FDA decision on Aflibercept 8 mg for treatment of patients with wet age-related macular degeneration (wAMD), diabetic macular edema (DME) and diabetic retinopathy.
Pending-
Valoctocogene Roxaparvovec (Resubmitted BLA)
06/30/2023
FDA decision on Valoctocogene Roxaparvovec for the treatment of severe hemophilia A in adult patients
Pending-
AVT04 (BLA)
2H 2023
FDA decision on AVT04, a proposed biosimilar to Stelara, which is prescribed to treat a variety of inflammatory conditions
Pending-
LEQEMBI (sBLA)
07/06/2023
FDA decision in determining whether to convert accelerated approval of Alzheimer's drug LEQEMBI to a traditional approval
Pending-
I/ONTAK (BLA)
07/28/2023
FDA decision on I/ONTAK for patients with persistent or recurrent cutaneous T-cell lymphoma (CTCL)
Pending-
- Forums
- ASX - By Stock
- 2023 The Final Countdown
https://www.rttnews.com/corpinfo/fdacalendar.aspxSubcutaneous...
-
-
- There are more pages in this discussion • 2,721 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.02 |
Change
0.015(1.49%) |
Mkt cap ! $1.164B |
Open | High | Low | Value | Volume |
$1.00 | $1.04 | 94.0¢ | $11.76M | 11.90M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 206912 | $1.02 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.03 | 37637 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 206912 | 1.015 |
8 | 195410 | 1.010 |
5 | 95607 | 1.005 |
7 | 208096 | 1.000 |
3 | 103747 | 0.995 |
Price($) | Vol. | No. |
---|---|---|
1.025 | 37637 | 1 |
1.030 | 29757 | 2 |
1.035 | 91225 | 3 |
1.040 | 72457 | 5 |
1.045 | 126212 | 4 |
Last trade - 16.10pm 31/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, CEO
Anthony Noble
CEO
SPONSORED BY The Market Online